Men's health features
Guest Editorial 3-1
End of life care and palliative care emergencies
Sexual dysfunction in young men: Part 2
COPD - Meeting the diagnostic challenge
Burning Questions On 2-6
End of life care - one chance to get it right
Meeting the challenge of sexual dysfunction in men: Part 1
Young men are often reluctant to present to their GP with sexual problems. When they do, a thorough and effective assessment is essential to ensure effective management. In this two-part series, the authors look at the key main sexual problems experienced by this patient group. Part 1 explores the landscape of male sexual dysfunction and looks at assessment and management of premature ejaculation.
Pain Management: Part 3
Cancer survivorship - The importance of ongoing care, Part 2
The role of SGLT2 inhibitors in Type 2 Diabetes
The advent of SGLT2 inhibitors, a new class of glucose lowering agent, currently represented by dapagliﬂozin (Forxiga)and canagliﬂozin (Invokana), offers a new mechanistic paradigm for treatment. Here, the authors consider the prescribing rationale and precautions, with an emphasis on the pharmacodynamic and kinetic properties of these agents.